BIOEN vs AKSEN Comparison
Price, market cap, valuation, profitability and leverage metrics of BIOEN and AKSEN side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | BIOEN | AKSEN | Sector median |
|---|---|---|---|
| Last price (TL) | 9.28 | 67.35 | 20.37 |
| Daily change | −9.02% | −6.46% | −5.55% |
| Market cap | TRY 4.6B | TRY 82.6B | TRY 10.8B |
| P/E | — | 23.94 | 14.38 |
| P/B | 1.56 | 1.29 | 1.09 |
| Dividend yield | — | 2.81% | 2.30% |
| Return on equity | −23.95% | 6.05% | 4.43% |
| Free float | 52.11% | 19.30% | 26.02% |
Popular comparisons
Related pages
About the BIOEN vs AKSEN comparison
Price, market cap, valuation multiples, profitability and leverage of BIOEN (Biotrend Cevre ve Enerji) and AKSEN (Aksa Enerji) side by side as of Sep 28, 2026, 11:43. Of the 15 metrics compared, BIOEN leads in 0 and AKSEN leads in 15.
Highlights: Daily change: AKSEN leads (−6.46% vs −9.02%). Market cap: AKSEN leads (TRY 82.6B vs TRY 4.6B). P/B: AKSEN leads (1.29 vs 1.56). EV/EBITDA: AKSEN leads (11.91 vs 85.99). EV/Sales: AKSEN leads (7.39 vs 7.58). Gross margin: AKSEN leads (30.89% vs −7.36%). EBITDA margin (annual): AKSEN leads (34.62% vs 5.02%). Net margin (annual): AKSEN leads (10.28% vs −34.61%).
Frequently asked questions
Is BIOEN or AKSEN cheaper?
By P/E, Tie is cheaper (— vs 23.94); by P/B, AKSEN trades at the lower multiple (1.56 vs 1.29).
Which is more profitable, BIOEN or AKSEN?
Annual net margin is −34.61% for BIOEN and 10.28% for AKSEN; return on equity is −23.95% for BIOEN and 6.05% for AKSEN.
Which is more leveraged, BIOEN or AKSEN?
The leverage ratio is 71.76 for BIOEN and 50.69 for AKSEN; net debt/EBITDA is 46.35 for BIOEN and 4.79 for AKSEN. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.